eKapija | Search news

Number of results: 19

Innovative Drug Against Multiple Sclerosis Available to Patients in Serbia

Thu 30.03.2023.

Peter Goldschmidt is new CEO of STADA, group which includes Hemofarm

Mon 03.09.2018.

STADA acquires rights to Nizoral brand from Johnson & Johnson

Thu 05.07.2018.

Hemofarm Vrsac becomes head center of Stada Group for Central-Eastern Europe – Further expansion of capacities and enhancement of production planned

Mon 05.02.2018.

Five companies interested in Galenika – Decision on debt conversion on August 14

Thu 10.08.2017.

Stada loses EUR 14.3 million in final quarter of 2016 – Company expects profit of around EUR 200 million in 2017

Thu 30.03.2017.

Hemofarm acquisitions in Serbia continue – Company focused on preventive medicine and OTC portfolio

Wed 01.02.2017.

In 2016 Hemofarm is planning to open facility for quality control and new products launch

Sun 13.12.2015.

Hemofarm pours EUR 22 m in production departments in 2015

Wed 21.01.2015.

Aleksandar Spajić, designer - CV

Thu 29.12.2011.